Physician's intent to comply with the American Medical Association's guidelines on gifts from the pharmaceutical industry

Journal of Medical Ethics

Volumn 33, Issue 6, 2007, Pages 313-319

  Pinto, Sharrel L ^a   Lipowski, Earlene ^b   Segal, Richard ^b   Kimberlin, Carole ^b   Algina, James ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BEHAVIOR; DRUG INDUSTRY; ETHICS; GIFT GIVING; HEALTH PERSONNEL ATTITUDE; HUMAN; MEDICAL EDUCATION; MEDICAL SOCIETY; MOTIVATION; PHYSICIAN; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; UNITED STATES;

AMERICAN MEDICAL ASSOCIATION; ATTITUDE OF HEALTH PERSONNEL; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; GIFT GIVING; GUIDELINE ADHERENCE; HUMANS; INTENTION; MOTIVATION; PHYSICIANS; UNITED STATES;

EID: 34250749040     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2005.015529     Document Type: Article

References (54)

1. Blumenthal D. Doctors and drug companies. N Eng J Med 2004;351:1885-90.
2. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry - self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-900.
3. Haayer F. Rational prescribing and sources of information. Soc Sci Med 1982;16:2017-23.
4. Bower AD, Burkett GL. Family physicians and generic drugs. J Family Pract 1987;24:612-16.
5. Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988;26:1183-9.
6. Caudill TS, Johnson MS, Rich EC, et al. Physicians, pharmaceutical sales representatives and the cost of prescribing. Arch Fam Med 1996;5:201-6.
7. National Institute for Health Care Management. Prescription drugs mass media advertising, www.nihcm.org/pharm.html (accessed 7 Feb 2007).
8. American Medical Association. Ethical opinions/guidelines - opinions E-8.061, "Gifts to physicians from industry", www.ama-assn.org/ama/pub/category/4001.html (accessed 7 Feb 2007).
9. Sagall RJ. Drug companies, dollars, and doctors. Pediatr Parents 1992;1:8.
10. Page L. Reactions to AMA gift code show rumblings in the ranks. Am Med News 1992;35:2.
11. Gibbons RV, Landry FJ, Blouch DL, et al. A comparison of physicians' and patients' attitudes toward pharmaceutical industry gifts. J Gen Intern Med 1998;13:151-4.
12. Steinman MA, Shilipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotion. Am J Med 2001;110:551-7.
13. Chimonas S, Rothman DJ. New federal guidelines for physician-pharmaceutical industry relations: the politics of policy formation. Health Affairs 2005;24:949-60.
14. Pettey S. OIG cautions drug industry on relations with physicians. Caring for the Ages 2002:1.
15. Pinto SL, Lipowski E, Segal R, et al. American Medical Association's guidelines on gifts to physicians: assessing intent to comply [dissertation]. Gainesville: University of Florida, 2004.
16. Panush RS. Not for sale, not even for rent: just say no. Thoughts about the American College of Rheumatology adopting a code of ethics. J Rheumatol 2002;29:1049-57.
17. Dana J, Loewenstein G. A social science perspective on gifts to physicians from industry. J Am Med Assoc 2003;290:252-5.
18. Coyle SL. Physician-industry relations: Part 1: Individual physicians. Ann Intern Med 2002;136:396-402.
19. Brubaker B. Drug firms still lavish pricey gifts on doctors, www.washingtonpost.com (accessed 7 Feb 2007).
20. Corpus TJ. Gifts to physicians from industry. JAMA 1991; 265:501.
21. Goldstein AO, LeBlond RF, Leung AK, et al. Gifts to physicians from industry. JAMA. 1991;266: 61, 63).
22. Howard SM. Gifts to physicians from the pharmaceutical industry. JAMA 2000;283:2655-8.
23. Komesaroff PA, Kerridge IH. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. MJA 2002;176:118-21.
24. Ray M. Who pays for the pizza? Redefining the relationship between doctors and drug companies. 1: Entanglement, BMJ 2003; 326:1189-92.
25. Shockman L. 'Drug companies' 'freebies' make Doctor Ross sick, lavish handouts are raising real ethical issues, critics say. The Blade 2003;A3.
26. Sweeney P. Drug company gifts: a response, www.brown.edu/ Administration/George_Street_Journal/vol27 (accessed 7 Feb 2007).
27. Wazana A. Gifts to physicians from the pharmaceutical industry. JAMA 2000;283:2655-8.
28. Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. 2nd edn. San Francisco, CA: Jossey-Bass Publishers, 1996.
29. Montano DE, K D, Taplin SH. The theory of reasoned action and the theory of planned behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. San Francisco, CA: Jossey-Bass Publishers, 1996:85-112.
30. Ajzen I. Constructing a TpB questionnaire: conceptual and methodological considerations, http://www.people.umass.edu/aizen/pdf/ tpb.measurement.pdf (accessed 7 Feb 2007).
31. Conner M, Kirk SF, Cade JE, et al. Environmental influences: factors influencing a woman's decision to use dietary supplements. Am Soc Nutr Sci 2003;133:1978S-82S.
32. Tolma EL, Reininger BM, Ureda J, et al. Cognitive motivations associated with screening mammography in Cyprus. Prev Med 2003;36:363-73.
33. Baranowski T, Cullen KW, Nicklas T, et al. Are current health behavior change models helpful in guiding prevention of weight gain efforts. Obesity Res 2003;11:23S-43S.
34. Liabsuetrakul T, Chongsuvivatwong V, Lumbiganon P, et al. Obstetricians' attitudes, subjective norms, perceived controls, and intentions on antibiotic phrophylaxix in caesarean section. Soc Sci Med 2003;57:1665-74.
35. Evans MG. The problem of analyzing multiplicative composities: interactions revisited. Am Psychol 1991;46:6-15.
36. Doll J, Orth B. The Fishbein and Ajzen theory of reasoned action applied to contraceptive behavior: model variants and meaningfulness. J Appl Soc Psychol 1993;23:395-415.
37. American Medical Association. Gifts to physicians - online self-study materials, http://www.ama-assn.org/ama/pub/category/ 8943.html (accessed 7 Feb 2007).
38. McCormick BB, Tomlinson G, Brill-Edwards P, et al. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001;286:1994-9.
39. Hoffman L, Enders JL, Luo J, et al. Impact of an antidepressant management program on medication adherence. Am J Manag Care 2003;9:70-80.
40. Fowler FJ, ed. Survey research methods. 2nd edn. Newbury Park, CA: Sage Publications, 1993.
41. Bower AD, Burkett GL. Family physicians and generic drugs. J Fam Pract 1987;24:612-16.
42. Yaldo, AZ. Effects of patient persuasion on physician prescribing of antibiotics [dissertation]. Gainesville: University of Florida, 2002.
43. Spector PE. Quantitative applications in the social sciences. In: Lewis-Beck MS, eds. Summated rating scale construction: an introduction. Newbury Park, CA: Sage Publications, 1992.
44. Hair JF, Anderson RE, Tatham RL, et al. Multivariate data anlysis. Upper Saddle River, NJ: Prentice-Hall, 1998.
45. Stevens J. Applied multivariate statistics for the social sciences, 4th edn. Mahwah, NJ: Lawrence Erlbaum Associates, 2002.
46. Bowman MA, Pearle DL. Changes in prescribing patterns related to commercial company funding of continuing medical education. J Continuing Edu Health Professions 1988;8:13-20.
47. Edwards DA. Gifts to physicians from the pharmaceutical industry. J Am Med Assoc 2000;283:2656-8.
48. Mahoney D. PhRMA code: no more trips to the ball game. Intern Med News 2003;35.
49. IMS Health. Total U.S. promotional spend by type in 2003. Promotional data: IMS Health, Integrated Promotional Services™ and CMR, 6/2004.
50. Ung D. California mandates comprehensive compliance programs for pharmaceutical companies. Drug Benefit Trends 2005; 17:242-3.
51. Araujo MT, Paiva T, Jesuino JC, et al. General practitioners and neurotelemedicine. Stud Health Technol Inform 2000;78:45-67.
52. Werner P, Mendelsson G. Nursing staff members' intentions to use physical restraints with older people: testing the theory of reasoned action. J Adv Nurs 2001;35:784-91.
53. Levin PF. Test of the Fishbein and Ajzen models as predictors of health care workers' glove use. Res Nurs Health 1999; 22:295-307.
54. Chren MM, Landefeld CS. Physicians' behavior and their interactions with drug companies: a controlled study of physicians who requested addition to a hospital formulary. J Am Med Assoc 1994; 271:684-6.